vs

Side-by-side financial comparison of Opus Genetics, Inc. (IRD) and Beyond Air, Inc. (XAIR). Click either name above to swap in a different company.

Opus Genetics, Inc. is the larger business by last-quarter revenue ($3.9M vs $2.2M, roughly 1.8× Beyond Air, Inc.). On growth, Beyond Air, Inc. posted the faster year-over-year revenue change (104.7% vs -10.2%). Over the past eight quarters, Beyond Air, Inc.'s revenue compounded faster (116.1% CAGR vs 50.3%).

Opus Genetics, Inc. is a clinical-stage biotechnology company specializing in the development of targeted gene therapies for inherited retinal diseases. It focuses on addressing unmet medical needs for patients living with rare, vision-threatening ocular conditions, with operations centered on advancing accessible therapeutic candidates for global rare disease patient populations.

Delta Air Lines, Inc. is a major airline in the United States headquartered in Atlanta, Georgia, operating nine hubs, with Hartsfield–Jackson Atlanta International Airport being its largest in terms of total passengers and number of departures. With its regional subsidiaries and contractors operating under the brand name Delta Connection, Delta has over 5,400 flights daily and serves 325 destinations in 52 countries on six continents.

IRD vs XAIR — Head-to-Head

Bigger by revenue
IRD
IRD
1.8× larger
IRD
$3.9M
$2.2M
XAIR
Growing faster (revenue YoY)
XAIR
XAIR
+114.8% gap
XAIR
104.7%
-10.2%
IRD
Faster 2-yr revenue CAGR
XAIR
XAIR
Annualised
XAIR
116.1%
50.3%
IRD

Income Statement — Q4 FY2025 vs Q3 FY2026

Metric
IRD
IRD
XAIR
XAIR
Revenue
$3.9M
$2.2M
Net Profit
$-7.3M
Gross Margin
13.7%
Operating Margin
-300.6%
Net Margin
-334.4%
Revenue YoY
-10.2%
104.7%
Net Profit YoY
53.0%
43.7%
EPS (diluted)
$-0.85

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IRD
IRD
XAIR
XAIR
Q4 25
$3.9M
$2.2M
Q3 25
$3.1M
$1.8M
Q2 25
$2.9M
$1.8M
Q1 25
$4.4M
$1.2M
Q4 24
$4.3M
$1.1M
Q3 24
$3.9M
$798.0K
Q2 24
$1.1M
$683.0K
Q1 24
$1.7M
$470.0K
Net Profit
IRD
IRD
XAIR
XAIR
Q4 25
$-7.3M
Q3 25
$-17.5M
$-7.9M
Q2 25
$-7.4M
$-7.7M
Q1 25
$-8.2M
$-8.0M
Q4 24
$-13.0M
Q3 24
$-7.5M
$-13.4M
Q2 24
$-7.8M
$-12.2M
Q1 24
$-7.1M
$-13.7M
Gross Margin
IRD
IRD
XAIR
XAIR
Q4 25
13.7%
Q3 25
-16.4%
Q2 25
8.9%
Q1 25
-2.8%
Q4 24
-20.1%
Q3 24
-135.8%
Q2 24
-48.6%
Q1 24
-109.4%
Operating Margin
IRD
IRD
XAIR
XAIR
Q4 25
-300.6%
Q3 25
-269.9%
-421.4%
Q2 25
-309.0%
-432.8%
Q1 25
-227.2%
-622.6%
Q4 24
-1021.6%
Q3 24
-207.1%
-1608.1%
Q2 24
-748.9%
-1988.3%
Q1 24
-450.5%
-2687.9%
Net Margin
IRD
IRD
XAIR
XAIR
Q4 25
-334.4%
Q3 25
-566.9%
-436.7%
Q2 25
-257.5%
-437.0%
Q1 25
-187.5%
-697.4%
Q4 24
-1215.7%
Q3 24
-194.6%
-1673.9%
Q2 24
-698.3%
-1786.4%
Q1 24
-415.3%
-2916.4%
EPS (diluted)
IRD
IRD
XAIR
XAIR
Q4 25
$-0.85
Q3 25
$-0.25
$-1.25
Q2 25
$-0.12
$-1.53
Q1 25
$-0.24
$13.26
Q4 24
$-2.96
Q3 24
$-0.29
$-5.67
Q2 24
$-0.30
$-5.32
Q1 24
$-0.29
$-0.36

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IRD
IRD
XAIR
XAIR
Cash + ST InvestmentsLiquidity on hand
$45.1M
$11.7M
Total DebtLower is stronger
Stockholders' EquityBook value
$15.3M
$8.1M
Total Assets
$50.2M
$36.8M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IRD
IRD
XAIR
XAIR
Q4 25
$45.1M
$11.7M
Q3 25
$30.8M
$10.7M
Q2 25
$32.4M
$6.5M
Q1 25
$41.8M
$6.9M
Q4 24
$30.3M
$10.9M
Q3 24
$36.6M
$28.4M
Q2 24
$41.4M
$21.4M
Q1 24
$47.2M
$34.5M
Total Debt
IRD
IRD
XAIR
XAIR
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
$11.8M
Q3 24
$12.5M
Q2 24
$17.5M
Q1 24
$17.5M
Stockholders' Equity
IRD
IRD
XAIR
XAIR
Q4 25
$15.3M
$8.1M
Q3 25
$6.0M
$12.7M
Q2 25
$17.5M
$9.9M
Q1 25
$5.1M
$13.6M
Q4 24
$6.7M
$17.6M
Q3 24
$34.3M
$28.1M
Q2 24
$40.6M
$16.1M
Q1 24
$46.1M
$25.0M
Total Assets
IRD
IRD
XAIR
XAIR
Q4 25
$50.2M
$36.8M
Q3 25
$36.1M
$31.0M
Q2 25
$38.7M
$28.1M
Q1 25
$48.2M
$30.1M
Q4 24
$36.9M
$34.1M
Q3 24
$40.4M
$53.0M
Q2 24
$44.8M
$46.5M
Q1 24
$51.8M
$57.0M
Debt / Equity
IRD
IRD
XAIR
XAIR
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
0.67×
Q3 24
0.44×
Q2 24
1.08×
Q1 24
0.70×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IRD
IRD
XAIR
XAIR
Operating Cash FlowLast quarter
$-35.3M
$-4.2M
Free Cash FlowOCF − Capex
$-4.3M
FCF MarginFCF / Revenue
-193.8%
Capex IntensityCapex / Revenue
1.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-22.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IRD
IRD
XAIR
XAIR
Q4 25
$-35.3M
$-4.2M
Q3 25
$-6.2M
$-4.5M
Q2 25
$-10.3M
$-4.5M
Q1 25
$-9.0M
$-7.0M
Q4 24
$-25.6M
$-7.7M
Q3 24
$-5.1M
$-13.3M
Q2 24
$-7.3M
$-10.2M
Q1 24
$-5.7M
$-10.7M
Free Cash Flow
IRD
IRD
XAIR
XAIR
Q4 25
$-4.3M
Q3 25
$-4.7M
Q2 25
$-4.7M
Q1 25
$-8.5M
Q4 24
$-8.3M
Q3 24
$-14.5M
Q2 24
$-12.9M
Q1 24
$-12.7M
FCF Margin
IRD
IRD
XAIR
XAIR
Q4 25
-193.8%
Q3 25
-258.5%
Q2 25
-268.4%
Q1 25
-733.9%
Q4 24
-771.5%
Q3 24
-1819.9%
Q2 24
-1881.8%
Q1 24
-2692.8%
Capex Intensity
IRD
IRD
XAIR
XAIR
Q4 25
1.5%
Q3 25
13.5%
Q2 25
11.3%
Q1 25
130.0%
Q4 24
50.1%
Q3 24
147.2%
Q2 24
391.4%
Q1 24
410.9%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons